Adam Ang
Selected early versions will be slated for real-world deployment.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.
What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes.
Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.
Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.
Trained on two million skin images, it can perform a range of clinical tasks unlike current models.
It has shown potential to significantly reduce pain intensity.
Also, fellow Korean medical AI companies have obtained regulatory approvals across global markets.
40% of their time is spent on manually collecting data, which the tool would assist in reducing.